Navigation Links
InVitria Headlines Sponsorship of WilBio's Waterside Conference
Date:4/9/2009

Supplier of high performance cell culture media components will reveal significant advantages of its products at the 14th International Meeting of The Waterside Conference, April 20-22 in San Francisco.

Fort Collins, CO (PRWEB) April 9, 2009 -- InVitria's line of high performance cell culture media components used for mammalian cell culture will be showcased at the upcoming Williamsburg BioProcessing Foundation The Waterside Conference on April 20-22, 2009, in South San Francisco.

Regarded as one of the leading events addressing scale-up and production issues facing the bioprocessing industry, the 2009 Waterside Conference comes at an opportune time for InVitria to share its product advantages with commercial biomanufacturers.

InVitria's Cellastim (recombinant human serum albumin) and Lacromin (recombinant Lactoferrin) have been used by large-scale commercial manufacturers to significantly improve CHO cell growth and productivity. Cellastim also increases hybridoma cell growth and monoclonal antibody production.

InVitria's Director of Cell Culture, Dr. Steve Pettit, will present two posters at the conference revealing the optimization benefits of InVitria's Cellastim in CHO and hybridoma cell lines. "Recent research from our own work and that of customers shows substantial improvements in the speed of cell line development and seed-train expansion using InVitria's recombinant product," said Dr. Pettit. "This is especially important for our customers who want to eliminate animal-derived components and also expedite their product development process," he continued.

"We are glad to partner with WilBio as a sponsor for this industry-leading event," commented Scott Deeter, InVitria President and CEO. "At The Waterside Conference, we invite existing and new customers to visit our booth to learn how InVitria can help you optimize productivity, reduce product development time and achieve your regulatory objectives."

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research and diagnostics.

For more information about InVitria's products, please contact us by e-mail or phone.

E-mail: info(at)InVitria(dot)com
Phone: 1-800-916-8311

###

Read the full story at http://www.prweb.com/releases/WilBioWaterside/InVitria/prweb2314714.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria Announces Launch of Recombinant Albumin for Diagnostics
2. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
3. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
4. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
5. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
6. InVitria to Present at WilBio's International Cell Engineering Meeting
7. Oprah Show Expert and RealAge Cofounder Headlines ePharma Talk
8. Good News in Africa: Beyond the headlines
9. Fitness Model / Entrepreneur Targets Childhood Obesity and Makes Headlines Nationwide With New Franchise Offering
10. NHS Choices Launches Medical News Guide to What Lies Behind the Headlines
11. THE Aesthetic Show Attracts Record Sponsorship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/13/2017)... ATLANTA , Sept. 13, 2017   OrthoAtlanta ... to the Atlanta Football Host Committee (AFHC) for the 2018 ... Monday, Jan. 8, 2018, at Mercedes-Benz Stadium in ... part of the AFHC "I,m In" campaign, participating in many ... ...
Breaking Medicine Technology: